EN PL
PRACA PRZEGLĄDOWA
Rycina z artykułu: Infrared thermography for...
 
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Raynaud’s phenomenon (RP) is a vasospastic disorder classified into primary (PRP) and secondary (SRP) forms. Infrared thermography (IRT), a non-invasive imaging technique assessing skin surface temperature, has emerged as a valuable tool in evaluating microvascular dysfunction in RP. This review analyzed literature from 2010 to 2025 across PubMed, Scopus, Web of Science, and Embase using key words including “Raynaud’s phenomenon,” “infrared thermography,” and “cold provocation test.” Studies focusing on diagnostic accuracy, differentiation of PRP from SRP, and monitoring treatment response were included. Infrared thermography demonstrates strong sensitivity and specificity, especially through parameters such as distal-dorsal temperature difference and rewarming kinetics. It offers a comfortable, reproducible alternative to traditional methods such as the finger systolic pressure test. However, lack of standardized imaging protocols and equipment variability limit its widespread use. Advancements in device calibration, artificial intelligence integration, and protocol harmonization could enhance IRT’s clinical utility in diagnosing and monitoring RP.
REFERENCJE (53)
1.
Mariotti A, Grossi G, Amerio P, et al. Finger thermoregulatory model assessing functional impairment in Raynaud’s phenomenon. Ann Biomed Eng 2009; 37: 2631–2639, DOI: 10.1007/s10439-009-9788-9.
 
2.
Grossi G, Mariotti A, Di Donato L, et al. Functional infrared imaging of paroxysmal ischemic events in patients with Raynaud’s phenomenon. Int J Immunopathol Pharmacol 2010; 23: 627–632, DOI: 10.1177/039463201002300225.
 
3.
Rogalski A. History of infrared detectors. Opto-Electron Rev 2012; 20: 279–308, DOI: 10.2478/s11772-012-0037-7.
 
4.
Wilkinson JD, Leggett SA, Marjanovic EJ, et al. A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography. Arthritis Rheumatol 2018; 70: 903–911, DOI: 10.1002/art.40457.
 
5.
Furst DE. Outcome measures in rheumatologic clinical trials and systemic sclerosis. Rheumatology (Oxford) 2008; 47 Suppl 5: v29–v30, DOI: 10.1093/rheumatology/ken269.
 
6.
Nawaz I, Nawaz Y, Nawaz E, et al. Raynaud’s Phenomenon: Reviewing the Pathophysiology and Management Strategies. Cureus 2022; 14: e21681, DOI: 10.7759/cureus.21681.
 
7.
Pauling JD, Hughes M, Pope JE. Raynaud’s phenomenon – an up- date on diagnosis, classification and management. Clin Rheumatol 2019; 38: 3317–3330, DOI: 10.1007/s10067-019-04745-5.
 
8.
Wigley FM, Flavahan NA. Raynaud’s Phenomenon. N Engl J Med 2016; 375: 556–565, DOI: 10.1056/NEJMra­-1507638.
 
9.
Hughes M, Snapir A, Wilkinson J, et al. Prediction and impact of attacks of Raynaud’s phenomenon, as judged by patient perception. Rheumatology (Oxford) 2015; 54: 1443–1447, DOI: 10.1093/rheumatology/kev002.
 
10.
Melville AR, Belch JJF. Raynaud phenomenon. In: Hochberg MC, Gravallese EM, Silman AJ, Smolen JS, Weinblatt ME, Weis- man MH (eds.). Rheumatology. 8th ed. Elsevier, Philadelphia 2023; p. 1345–1350.
 
11.
Maverakis E, Patel F, Kronenberg DG, et al. International consensus criteria for the diagnosis of Raynaud’s phenomenon. J Autoimmun 2014; 48–49: 60–65, DOI: 10.1016/j.jaut. 2014.01.020.
 
12.
Herrick AL. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol 2012; 8: 469–479, DOI: 10.1038/nrrheum.2012.96.
 
13.
Aarhus L, Stranden E, Nordby KC, et al. Vascular component of hand-arm vibration syndrome: a 22-year follow-up study. Occup Med (Lond) 2018; 68: 384–390, DOI: 10.1093/occmed/kqy085.
 
14.
Nielsen SL. Raynaud phenomena and finger systolic pressure during cooling. Scand J Clin Lab Invest 1978; 38: 765–770, DOI: 10.1080/00365517809104885.
 
15.
Hughes M, Herrick AL. Raynaud’s phenomenon. Best Pract Res Clin Rheumatol 2016; 30: 112–132, DOI: 10.1016/j.berh. 2016.04.001.
 
16.
Smith V, Herrick AL, Ingegnoli F, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev 2020; 19: 102458, DOI: 10.1016/j.autrev.2020.102458.
 
17.
Prete M, Fatone MC, Favoino E, Perosa F. Raynaud’s phenome­non: from molecular pathogenesis to therapy. Autoimmun Rev 2014; 13: 655–667, DOI: 10.1016/j.autrev.2013.12.001.
 
18.
Jones GT, Herrick AL, Woodham SE, et al. Occurrence of Raynaud’s phenomenon in children ages 12-15 years: prevalence and association with other common symptoms. Arthritis Rheum 2003; 48: 3518–3521, DOI: 10.1002/art.11340.
 
19.
Nigrovic PA, Fuhlbrigge RC, Sundel RP. Raynaud’s phenomenon in children: a retrospective review of 123 patients. Pedia­trics 2003; 111: 715–721, DOI: 10.1542/peds.111.4.715.
 
20.
Martini G, Foeldvari I, Russo R, et al. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 2006; 54: 3971–3978, DOI: 10.1002/art.22207.
 
21.
Russo RA, Katsicas MM. Clinical characteristics of children with Juvenile Systemic Sclerosis: follow-up of 23 patients in a single tertiary center. Pediatr Rheumatol Online J 2007; 5: 6, DOI: 10.1186/1546-0096-5-6.
 
22.
Lindberg L, Kristensen B, Thomsen JF, et al. Characteristic Features of Infrared Thermographic Imaging in Primary Raynaud’s Phenomenon. Diagnostics (Basel) 2021; 11: 558, DOI: 10.3390/diagnostics11030558.
 
23.
Chaparro YC, González Gómez A, Carvajal Flechas F, et al. Detection of vascular changes in Raynaud’s phenomenon when capillaroscopy and thermography are used. Systematic literature review. Revista Colombiana de Reumatología (English Edition) 2023; 30: 137–149, DOI: 10.1016/j.rcreue.2021.05.007.
 
24.
Brunner-Ziegler S, Dassler E, Müller M, et al. Capillaroscopic differences between primary Raynaud phenomenon and healthy controls indicate potential microangiopathic involvement in benign vasospasms. Vasc Med 2024; 29: 200–207, DOI: 10.1177/1358863X231223523.
 
25.
Cherkas LF, Carter L, Spector TD, et al. Use of thermographic criteria to identify Raynaud’s phenomenon in a population setting. J Rheumatol 2003; 30: 720–722.
 
26.
von Bierbrauer A, Schilk I, Lucke C, Schmidt JA. Infrared thermography in the diagnosis of Raynaud’s phenomenon in vibration-induced white finger. Vasa 1998; 27: 94–99.
 
27.
Knyszyńska A, Radecka A, Lubkowska A. Thermal Imaging of Exercise-Associated Skin Temperature Changes in Swimmers Subjected to 2-min Intensive Exercise on a VASA Swim Bench Ergometer. Int J Environ Res Public Health 2021; 18: 6493, DOI: 10.3390/ijerph18126493.
 
28.
Kelly G. Body temperature variability (Part 1): a review of the history of body temperature and its variability due to site selection, biological rhythms, fitness, and aging. Altern Med Rev 2006; 11: 278–293.
 
29.
Kelly GS. Body temperature variability (Part 2): masking influences of body temperature variability and a review of body temperature variability in disease. Altern Med Rev 2007; 12: 49–62.
 
30.
Kesztyüs D, Brucher S, Wilson C, Kesztyüs T. Use of Infrared Thermography in Medical Diagnosis, Screening, and Disease Monitoring: A Scoping Review. Medicina (Kaunas) 2023; 59: 2139, DOI: 10.3390/medicina59122139.
 
31.
Filho AVD, Packer AC, Costa AC de S, Rodrigues-Bigaton D. Accuracy of Infrared Thermography of the Masticatory Muscles for the Diagnosis of Myogenous Temporomandibular Disorder. J Manipulative Physiol Ther 2013; 36: 245–252, DOI: 10.1016/ j.jmpt.2013.04.007.
 
32.
Park JY, Hyun JK, Seo JB. The effectiveness of digital infrared thermographic imaging in patients with shoulder impingement syndrome. J Shoulder Elbow Surg 2007; 16: 548–554, DOI: 10.1016/j.jse.2006.11.010.
 
33.
Zhang Q, Wu Y, Song Y, et al. Screening Evaporative Dry Eyes Severity Using an Infrared Image. J Ophthalmol 2021; 2021: 8396503, DOI: 10.1155/2021/8396503.
 
34.
Sillero-Quintana M, Fernández-Jaén T, Fernández-Cuevas I, et al. Infrared Thermography as a Support Tool for Screening and Early Diagnosis in Emergencies. J Med Imaging Health Inform 2015; 5: 1223–1228, DOI: 10.1166/jmihi.2015.1511.
 
35.
Tan LL, Sanjay S, Morgan PB. Screening for dry eye disease using infrared ocular thermography. Cont Lens Anterior Eye 2016; 39: 442–449, DOI: 10.1016/j.clae.2016.08.004.
 
36.
Ferraris A, Bouisse C, Mottard N, et al. Mottling score and skin temperature in septic shock: Relation and impact on prognosis in ICU. PLoS One 2018; 13: e0202329, DOI: 10.1371/journal.pone.0202329.
 
37.
Gatt A, Mercieca C, Borg A, et al. Thermal characteristics of rheumatoid feet in remission: Baseline data. PLoS One 2020; 15: e0243078, DOI: https://doi.org/10.1371/journa....
 
38.
Weibel L, Howell KJ, Visentin MT, et al. Laser Doppler flow­metry for assessing localized scleroderma in children. Arthritis Rheum 2007; 56: 3489–3495, DOI: 10.1002/art.22920.
 
39.
Ring EFJ, Ammer K. The Technique of Infra red Imaging in Medi­cine. Thermology International 2000; 10: 7–14, DOI: 10.1088/ 978-0-7503-1143-4ch1.
 
40.
Ring EFJ, Ammer K. Infrared thermal imaging in medicine. Physiol Meas 2012; 33: R33–R46, DOI: 10.1088/0967-3334/33/3/R33.
 
41.
Martini G, Cappella M, Culpo R, et al. Infrared thermography in children: a reliable tool for differential diagnosis of periphe­ral microvascular dysfunction and Raynaud’s phenomenon? Pediatr Rheumatol Online J 2019; 17: 68, DOI: 10.1186/s12969-019-0371-0.
 
42.
Schuhfried O, Vacariu G, Lang T, et al. Thermographic parameters in the diagnosis of secondary Raynaud’s phenomenon. Arch Phys Med Rehabil 2000; 81: 495–499, DOI: 10.1053/mr.2000.4870.
 
43.
Sternbersky J, Tichy M, Zapletalova J. Infrared thermography and capillaroscopy in the diagnosis of Raynaud’s phenomenon. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021; 165: 90–98, DOI: 10.5507/bp.2020.031.
 
44.
Lindberg L, Kristensen B, Eldrup E, et al. Infrared Thermography as a Method of Verification in Raynaud’s Phenomenon. Dia­gnostics (Basel) 2021; 11: 981, DOI: 10.3390/diagnostics11060981.
 
45.
Herrick AL, Dinsdale G, Murray A. New perspectives in the imaging of Raynaud’s phenomenon. Eur J Rheumatol 2020; 7: S212–S221, DOI: 10.5152/eurjrheum.2020.19124.
 
46.
Schlager O, Gschwandtner ME, Herberg K, et al. Correlation of infrared thermography and skin perfusion in Raynaud patients and in healthy controls. Microvasc Res 2010; 80: 54–57, DOI: 10.1016/j.mvr.2010.01.010.
 
47.
Coleiro B, Marshall SE, Denton CP, et al. Treatment of Raynaud’s phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology (Oxford) 2001; 40: 1038–1043, DOI: 10.1093/rheumatology/40.9.1038.
 
48.
Dziadzio M, Denton CP, Smith R, et al. Losartan therapy for Raynaud’s phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis Rheum 1999; 42: 2646–2655, DOI: 10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T.
 
49.
Ture HY, Lee NY, Kim NR, Nam EJ. Raynaud’s Phenomenon: A Current Update on Pathogenesis, Diagnostic Workup, and Treatment. Vasc Specialist Int 2024; 40: 26, DOI: 10.5758/vsi.240047.
 
50.
Bartelink ML, Wollersheim H, Leesmans E, et al. A standar­dized finger cooling test for Raynaud’s phenomenon: diagnostic value and sex differences. Eur Heart J 1993; 14: 614–622, DOI: 10.1093/eurheartj/14.5.614.
 
51.
Bovenzi M. Finger systolic pressure during local cooling in normal subjects aged 20 to 60 years: reference values for the assessment of digital vasospasm in Raynaud’s phenomenon of occupational origin. Int Arch Occup Environ Health 1988; 61: 179–181, DOI: 10.1007/BF00381016.
 
52.
Olsen N. Standardization of finger systolic blood pressure (FSBP) cooling tests. Environ Health Prev Med 2005; 10: 360–365, DOI: 10.1007/BF02898197.
 
53.
Pauling JD, Shipley JA, Harris ND, McHugh NJ. Use of infrared thermography as an endpoint in therapeutic trials of Raynaud’s phenomenon and systemic sclerosis. Clin Exp Rheumatol 2012; 30 (2 Suppl 71): S103–S115.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top